Best Weight Loss Injections for Women in 2026: Ranked and Reviewed

Semaglutide and tirzepatide are not gender-specific drugs, so the medication itself is identical whoever takes it. The program wrapped around it is what differs. In trial data, women lose weight on GLP-1s at rates equal to or a little above men's, and the questions that genuinely change which provider suits you are PCOS, perimenopause, how tirzepatide interacts with birth control, and pregnancy planning. Ranked below are injectable GLP-1 providers with real depth on exactly that: menopause-certified clinicians, programs that account for PCOS, and platforms built around women's care.

Lowest verified price: $79/mo14 providers compared

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

14 weight loss injections for women compared · independently scored against our six-factor methodology.

Quick Picks

Starting price per provider. Prices in USD per month; checked October 2026.
#ProviderScore
1EmbodyVisit
2FoundVisit
3Queen RXVisit
4MEDViVisit
5WillowVisit

Compare the top providers at a glance

Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.

  • ★ Editor's Pick
    Embody

    a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies

    From /mo
    $79
    Coverage
    50 states + DC
    Medications
    SemaglutideTirzepatide
  • Nationwide Coverage
    Found

    people who want clinician visits billed to commercial insurance, with compounded medication in the plan price

    From /mo
    $149+ membership
    Coverage
    50 states
    Medications
    SemaglutideTirzepatideOrforglipron
  • Best Budget
    Queen RX

    a one-time 3-month semaglutide pack with no subscription

    From /mo
    $100prepaid
    Coverage
    44 states
    Medications
    SemaglutideTirzepatide
Show 5 more
  • MEDVi

    knowing which pharmacy fills the vial: it names Triad Rx

    From /mo
    $199
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
  • Willow

    seeing what it charges before you answer any medical questions

    From /mo
    $299
    Coverage
    35 states
    Medications
    SemaglutideTirzepatide
  • Best Care Team
    Mochi Health

    coaching bundled into the price rather than sold separately

    From /mo
    $110
    Coverage
    50 states
    Medications
    SemaglutideTirzepatideOrforglipron
  • Freya Meds

    a GLP-1-only service with unlimited doctor access and monthly group calls

    From /mo
    $250prepaid
    Coverage
    47 states
    Medications
    SemaglutideTirzepatide
  • Wisp

    an oral route if you will not self-inject

    From /mo
    $225
    Coverage
    39 states
    Medications
    SemaglutideTirzepatide
All 14 providers on this board, in the order this board shows them

The comparison above shows the first 8. This is the full list the filter counts refer to, in the order this board shows them; each name opens that provider’s review.

6weighted dimensions
14weight loss injections for women compared
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →

Detailed Reviews

1

Embody

Verified partner

Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies

9.3

Embody is the brand Modern Metabolic Medicine, Inc. runs through its JoinEm storefront. It sells compounded semaglutide and tirzepatide injections at one price per drug at every dose, $79 and $129 for a one-month supply, plus a compounded oral tirzepatide gum. You pay at checkout, before an OpenLoop Health clinician decides on a prescription, and payments are final.

Score Breakdown

Value25%
10
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
9
Accessibility10%
10
Support10%
7

Pros

  • ✓Semaglutide costs $79 a month, 60% below the $199 median for compounded semaglutide across the sellers we compare
  • ✓Tirzepatide costs $129 a month, 52% below the $269 median for compounded tirzepatide across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price includes the medication, clinician visits and shipping
  • ✓Serves all 50 states and DC
  • ✓Names 4 pharmacies that fill its prescriptions, which most sellers do not
  • ✓We found no FDA warning letters issued to Embody

Cons

  • ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
2

Found

Verified partner

Best for: people who want clinician visits billed to commercial insurance, with compounded medication in the plan price

7.3

Found is a weight-care program with board-certified clinicians, coaching and an app. Its compounded plans bundle medication and membership at one price per dose, billed every 4 weeks. Brand-name drugs are billed separately from the membership. Month to month, compounded semaglutide is $289 and tirzepatide $359; the $169 rate on its pricing page requires 12 months paid up front.

Score Breakdown

Value25%
3
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
7.5
Accessibility10%
10
Support10%
7

Pros

  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price includes the medication, clinician visits and coaching
  • ✓Serves all 50 states
  • ✓We found no FDA warning letters issued to Found

Cons

  • ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
  • ✗Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Starting from $149/mo + membershipRead full review →
Visit Found →
3

Queen RX

Best for: a one-time 3-month semaglutide pack with no subscription

7.8
Score breakdown, pros and cons

Queen RX, run by Mini Labs, LLC, sells compounded semaglutide and tirzepatide as one-time 3-month packs with no subscription. A semaglutide starter pack is $299 up front, about $100 a month; tirzepatide packs run $499 to $599. The price covers the doctor consult and supplies. It sells in 44 states; California, Kansas, Louisiana, Mississippi, New Mexico and West Virginia are excluded.

Score Breakdown

Value25%
6
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
7.5
Accessibility10%
9
Support10%
5.5

Pros

  • ✓Semaglutide costs $133 a month, 33% below the $199 median for compounded semaglutide across the sellers we compare
  • ✓Tirzepatide costs $200 a month, 26% below the $269 median for compounded tirzepatide across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price includes the medication and clinician visits
  • ✓Serves 44 states
  • ✓We found no FDA warning letters issued to Queen RX

Cons

  • ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
  • ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Starting from $100/mo, prepaidRead full review →
Visit Queen RX →
4

MEDVi

Best for: knowing which pharmacy fills the vial: it names Triad Rx

7.7
Score breakdown, pros and cons

MEDVi charges $99 for the first month of compounded semaglutide injections, then $199 a month; its dissolvable tablets start at $249. Brand Wegovy, as a pill or pen, and Zepbound carry a $99 monthly membership plus a drug cost it does not publish. Clinicians come from CareGLP Affiliated P.C.s and OpenLoop Health. FDA sent MEDVi a warning letter in February 2026.

Score Breakdown

Value25%
5
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
6
Accessibility10%
10
Support10%
8.5

Pros

  • ✓Semaglutide costs $199 a month, exactly the $199 median for compounded semaglutide across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price includes the medication, clinician visits, shipping and coaching
  • ✓Serves all 50 states
  • ✓Names 3 pharmacies that fill its prescriptions, which most sellers do not

Cons

  • ✗The FDA has issued MEDVi a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • ✗Its compounded semaglutide is not FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
5

Willow

Best for: seeing what it charges before you answer any medical questions

7.3
Score breakdown, pros and cons

Tablets and injections are both on offer at Willow, a telehealth seller of compounded GLP-1 medications.

Score Breakdown

Value25%
3
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
9
Accessibility10%
7.6
Support10%
7

Pros

  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price includes the medication, clinician visits and shipping
  • ✓Names 5 pharmacies that fill its prescriptions, which most sellers do not
  • ✓We found no FDA warning letters issued to Willow

Cons

  • ✗Serves only 35 states, so check that yours is one of them
  • ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

What a woman should check on a GLP-1 seller

Sex does not change the medication. It does change what competent care around the medication looks like. Depth on PCOS, on menopause, and on pregnancy planning is where the sellers on this page separate from one another.

What to check

  • Hormonal health, covered or not. Weight and GLP-1 response both shift with PCOS and with perimenopause. Some sellers staff menopause-certified clinicians, or run a program written with PCOS in mind. A generic telehealth intake collects none of that information and so cannot act on it.
  • Birth control and pregnancy in the intake. Oral contraception can be made less effective by tirzepatide, and a GLP-1 has to be stopped ahead of a pregnancy. Both facts belong in the intake form. Where they appear in a footnote instead, or nowhere, no screening happened.
  • Anything addressing lean mass. Lean tissue leaves alongside fat when loss is fast. Protein targets and resistance training are how that is limited. Some sellers build both into the program and others ship the drug by itself.

Red flags

  • Pharmacy unnamed and no LegitScript listing. Two disclosures are checkable on any compounded-GLP-1 seller: the 503A or 503B pharmacy filling the vial, and a LegitScript certification. When a site publishes neither, nothing about the contents of that vial can be confirmed from outside.
  • Instant approval with no clinician you can reach. A prescriber is supposed to read the intake and stay available once dose questions start. Approval issued automatically, with nobody reachable afterward, means the medical layer was removed rather than streamlined.
  • The advertised number is a first month. Headline figures here are usually qualified somewhere. Common forms are an opening rate that steps up with each dose increase, and a membership fee billed separately from the drug itself. Either one can double what leaves your account in month two.
  • B12, MIC, or HCG sold for weight loss. Trial evidence for weight loss sits with the GLP-1 injections and nowhere else on this aisle. A clinic that lists lipotropic, B12, or HCG shots under weight loss is selling past the record, whatever its own site says.

Every seller listed above is scored on these criteria under our six-dimension methodology, with prices re-checked against the seller’s own live site.

How we rank, and what counts as “legit”

Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.

Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].

How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].

Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Frequently Asked Questions

The main side effects are the same across every GLP-1 injection: nausea, constipation and other GI symptoms, which usually fade as the dose rises slowly. No molecule is clearly the 'gentler' one, and tolerability for semaglutide and tirzepatide is comparable. Slow titration, and a provider willing to adjust the dose, matter more than which drug you are on.
Neither the medication nor the dosing changes by sex; semaglutide and tirzepatide are not gender-specific. The care around them is what differs, covering PCOS, perimenopause, how tirzepatide interacts with birth control, and pregnancy planning. Providers ranked above carry women's-health depth for exactly those questions, with menopause-certified clinicians and PCOS-aware programs.
No. Pregnancy and attempts to conceive are both situations where GLP-1 medications are not recommended, and labels advise that semaglutide be stopped at least two months ahead of a planned pregnancy. Where pregnancy is a possibility, raise the question of timing, and of reliable contraception, with your prescriber before starting.
Six weighted dimensions produce the score. Value (25%) and Effectiveness (25%) carry the most, then User Experience (15%) and Trust & Safety (15%), then Accessibility (10%) and Support (10%). Behind them sits our research into pricing data, clinical evidence, user reviews and publicly available information. Those weights then combine into one overall score out of 10.
The six-dimension methodology computes each score on its own, and no commercial relationship ever moves a provider's underlying number. Every provider's full score sits on its card for you to check. Some providers do hold affiliate agreements with us, which means a commission reaches us if you click through and buy. On the lists carrying the highest commercial intent — the weight-loss injection and shot lists, the semaglutide and tirzepatide lists, the compounded and cheapest molecule lists, and the fitness-app list — affiliate partners take the top positions. Every other list runs in score order, or in price order on the cheapest lists. That placement is disclosed here, on our methodology page, and on our affiliate-disclosure page.
Sources & methodology — as of November 2026
  1. 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  5. 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  8. 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
  9. 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  10. 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
  11. 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.